NCT03595800View on ClinicalTrials.gov

Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen

PHASE3CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 19, 2017

Primary Completion Date

February 2, 2021

Study Completion Date

March 12, 2021

Conditions
Acute LeukemiaNon Hodgkin LymphomaMultiple Myeloma
Interventions
PROCEDURE

Hematopoietic stem cells transplantation

Allogeneic Hematopoietic stem cells transplantation

Trial Locations (1)

13009

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT03595800 - Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen | Biotech Hunter | Biotech Hunter